Persistent Sexual Side Effects after SSRI Discontinuation
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
New withdrawal symptoms may occur with any type of SSRI, but paroxetine is the most likely to be associated with new symptoms, while fluoxetine is the least associated.
“A bulk of literature, derived from controlled trials [18, 110, 111], case reports [19], and patients' online reports [112], showed that new withdrawal symptoms may occur with any type of SSRI, but paroxetine is the most likely to be associated with new symptoms, while fluoxetine being the least associated.”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [110]
Cites
Men and women differ in amygdala response to visual sexual stimuli
Hamann, S., Herman, R. A., Nolan, C. L., & Wallen, K. (2004) · Nature Neuroscience · doi:10.1038/nn1208 · Cited by 603 · see citing works
Mechanism of action of serotonin selective reuptake inhibitors
Stahl, S. M. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00221-3 · Cited by 540 · see citing works
Selective Serotonin-Reuptake Inhibitor–Induced Movement Disorders
Gerber, P. E., & Lynd, L. D. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17302 · Cited by 267 · see citing works
Hu, X. H., Bull, S. A., Hunkeler, E. M., Ming, E., Lee, J. Y., Fireman, B., & Markson, L. E. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0712 · Cited by 235 · see citing works
Can long-term treatment with antidepressant drugs worsen the course of depression?
Fava, G. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0204 · Cited by 223 · see citing works
Opbroek, A., Delgado, P. L., Laukes, C., McGahuey, C., Katsanis, J., Moreno, F. A., & Manber, R. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002870 · Cited by 147 · see citing works
Szeszko, P. R., MacMillan, S., McMeniman, M., Lorch, E., Madden, R., Ivey, J., Banerjee, S. P., Moore, G. J., & Rosenberg, D. R. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300399 · Cited by 141 · see citing works
Mechanisms and treatments of SSRI-induced sexual dysfunction.
Keltner, N. L., McAfee, K. M., & Taylor, C. L. (2002) · PubMed · Cited by 101 · see citing works
Selective serotonin reuptake inhibitor discontinuation syndrome: A review
Tamam, L., & Özpoyraz, N. (2002) · Advances in Therapy · doi:10.1007/bf02850015 · Cited by 69 · see citing works
Antidepressant-elicited changes in gene expression
Yamada, M., Yamada, M., & Higuchi, T. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.03.022 · Cited by 34 · see citing works
Montejo, A. L., Llorca, G., Izquierdo, J. A., et al. (2002) · PubMed · Cited by 19 · see citing works
Role of Serotonin in Feedback Control of Hypothalamic-Pituitary-Testicular Complex in Male Rats
Naumenko, E. V., & Shishkina, G. T. (2008) · Neuroendocrinology · doi:10.1159/000122791 · Cited by 15 · see citing works
Surviving Panic Disorder: What You Need to Know
Shipko, S. (2003) · Medical Entomology and Zoology · Cited by 1 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650 · see citing works
Davies, J., & Read, J. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.08.027 · Cited by 387 · see citing works
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265 · see citing works
Review: problems associated with long-term treatment with selective serotonin reuptake inhibitors
Moret, C., Isaac, M., & Briley, M. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108093582 · Cited by 135 · see citing works
Healy, D., Le Noury, J., & Mangin, D. (2018) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-180744 · Cited by 81 · see citing works
Bahrick, A. S. (2008) · The Open Psychology Journal · doi:10.2174/1874350100801010042 · Cited by 41 · see citing works
Citizen petition: Sexual side effects of SSRIs and SNRIs
Healy, D. (2018) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-180745 · Cited by 32 · see citing works
Patacchini, A., & Cosci, F. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001154 · Cited by 10 · see citing works
- Authors
- Csoka, A. B., & Shipko, S.
- Affiliations
- University of Pittsburgh (US)
- ORCID
- Csoka, Antonei B.
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2006
- Volume
- 75
- Issue
- 3
- Pages
- 187-188
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2049962820
- Cited by
- 92
- References
- 13
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 6 · 2023: 6 · 2022: 5 · 2021: 7 · 2020: 4 · 2019: 10 · 2018: 5 · 2017: 4 · 2016: 3 · 2015: 4 · 2014: 4 · 2013: 1 · 2012: 1
- FWCI
- 4.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Keywords
- selective serotonin reuptake inhibitors, SSRI discontinuation, sexual side effects, antidepressant side effects, sexual dysfunction
- MeSH terms
- Sildenafil Citrate, Cabergoline, Adult, Androgens, Anxiety, Depressive Disorder, Ergolines, Female, Fluoxetine, Humans, Sleep Initiation and Maintenance Disorders, Male, Monoamine Oxidase Inhibitors, Piperazines, Plants, Medicinal, Purines, Selegiline, Sulfones, Testosterone, Time Factors, Vasodilator Agents, Citalopram, Bupropion, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Dopamine Agonists, Dopamine Uptake Inhibitors, Sexual Dysfunctions, Psychological, Sertraline
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
